4854 studies found for:    "Hematologic Agents"
Show Display Options
Rank Status Study
1 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
2 Recruiting Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Intervention: Drug: Infusion Tranexamic acid or placebo.
3 Recruiting RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke
Conditions: Stroke, Acute;   Atrial Fibrillation
Intervention: Other: This is an observational study
4 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
7 Recruiting Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
8 Completed Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Stent Thrombosis;   Heart Diseases;   Acute Coronary Syndrome
Intervention: Drug: Clopidogrel
9 Not yet recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
10 Terminated Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy
Condition: Brain Metastases
Intervention: Radiation: Radiotherapy
11 Unknown  Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
Condition: Acute Ischemic Stroke
Intervention:
12 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
13 Recruiting The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
14 Recruiting Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Condition: Polycythemia Vera
Intervention:
15 Active, not recruiting A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy
Condition: Osteosarcoma
Intervention: Drug: Methotrexate,Calcium folinate
16 Withdrawn Penetration of Ertapenem Into Bone
Condition: Amputation
Intervention: Drug: ertapenem
17 Recruiting Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
18 Completed Can Recombinant Human Intrinsic Factor Be Used for Evaluation of the Vitamin B12 Absorption?
Condition: Vitamin B12 Deficiency
Intervention: Drug: Recombinant human intrinsic factor
19 Completed Iron Status and Hypoxic Pulmonary Vascular Responses
Conditions: Lung Hypoxia;   Pulmonary Arterial Hypertension;   Iron Deficiency
Interventions: Drug: Intravenous administration of ferric carboxymaltose;   Other: Subacute hypoxic exposures
20 Completed Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Pancreatic Cancer;   Thromboembolism
Interventions: Drug: dalteparin;   Drug: gemcitabine hydrochloride;   Other: diagnostic laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years